These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30909233)

  • 1. The Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer's Disease Risk.
    Belbin O; Morgan K; Medway C; Warden D; Cortina-Borja M; van Duijn CM; Adams HHH; Frank-Garcia A; Brookes K; Sánchez-Juan P; Alvarez V; Heun R; Kölsch H; Coto E; Kehoe PG; Rodriguez-Rodriguez E; Bullido MJ; Ikram MA; Smith AD; Lehmann DJ
    J Alzheimers Dis; 2019; 68(4):1535-1547. PubMed ID: 30909233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.
    Combarros O; Warden DR; Hammond N; Cortina-Borja M; Belbin O; Lehmann MG; Wilcock GK; Brown K; Kehoe PG; Barber R; Coto E; Alvarez V; Deloukas P; Gwilliam R; Heun R; Kölsch H; Mateo I; Oulhaj A; Arias-Vásquez A; Schuur M; Aulchenko YS; Ikram MA; Breteler MM; van Duijn CM; Morgan K; Smith AD; Lehmann DJ
    BMC Med Genet; 2010 Nov; 11():162. PubMed ID: 21070631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.
    Mustapic M; Presecki P; Pivac N; Mimica N; Hof PR; Simic G; Folnegovic-Smalc V; Muck-Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():94-9. PubMed ID: 23416088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration.
    Honea RA; Cruchaga C; Perea RD; Saykin AJ; Burns JM; Weinberger DR; Goate AM;
    PLoS One; 2013; 8(9):e76001. PubMed ID: 24086677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.
    Babić Leko M; Nikolac Perković M; Klepac N; Švob Štrac D; Borovečki F; Pivac N; Hof PR; Šimić G
    J Alzheimers Dis; 2020; 73(1):135-145. PubMed ID: 31771069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic epistasis regulates amyloid deposition in resilient aging.
    Felsky D; Xu J; Chibnik LB; Schneider JA; Knight J; Kennedy JL; ; Bennett DA; De Jager PL; Voineskos AN
    Alzheimers Dement; 2017 Oct; 13(10):1107-1116. PubMed ID: 28322202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.
    Andersson CH; Hansson O; Minthon L; Andreasen N; Blennow K; Zetterberg H; Skoog I; Wallin A; Nilsson S; Kettunen P
    J Alzheimers Dis; 2016 Jul; 53(4):1353-63. PubMed ID: 27392867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer's Disease, Parkinson's Disease and Schizophrenia: Evidence Based on Currently Available Loci.
    Tang S; Yao B; Li N; Lin S; Huang Z
    Cell Physiol Biochem; 2018; 51(1):411-428. PubMed ID: 30453293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
    J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease.
    Bullock JM; Medway C; Cortina-Borja M; Turton JC; Prince JA; Ibrahim-Verbaas CA; Schuur M; Breteler MM; van Duijn CM; Kehoe PG; Barber R; Coto E; Alvarez V; Deloukas P; Hammond N; Combarros O; Mateo I; Warden DR; Lehmann MG; Belbin O; Brown K; Wilcock GK; Heun R; Kölsch H; Smith AD; Lehmann DJ; Morgan K
    Neurobiol Aging; 2013 Apr; 34(4):1309.e1-7. PubMed ID: 23036584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.
    Chuu JY; Taylor JL; Tinklenberg J; Noda A; Yesavage J; Murphy GM
    J Alzheimers Dis; 2006 Mar; 9(1):43-9. PubMed ID: 16627933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.
    Kitzlerová E; Fišar Z; Lelková P; Jirák R; Zvěřová M; Hroudová J; Manukyan A; Martásek P; Raboch J
    Med Sci Monit; 2018 Apr; 24():2599-2619. PubMed ID: 29703883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).
    Reitz C; Tosto G; Vardarajan B; Rogaeva E; Ghani M; Rogers RS; Conrad C; Haines JL; Pericak-Vance MA; Fallin MD; Foroud T; Farrer LA; Schellenberg GD; George-Hyslop PS; Mayeux R;
    Transl Psychiatry; 2013 May; 3(5):e256. PubMed ID: 23673467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Plasma Brain-derived Neurotrophic Factor Level and Alzheimer's Disease: A Mendelian Randomization Study.
    You J; Wang Y; Chang X; Liu Y; He Y; Zhou X; Zou J; Xiao M; Shi M; Guo D; Shen O; Zhu Z
    Curr Neurovasc Res; 2024; 20(5):553-559. PubMed ID: 38279765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactor Dimensionality Reduction Analysis to Evaluate the Association of Dopamine Beta-Hydroxylase (DΒH) Polymorphisms with Susceptibility to Dementia (SADEM Study).
    Juárez-Cedillo T; Martínez-Rodríguez N; Fragoso JM; Islas-Pérez V; López-Martínez A; Valle-Medina A
    Mol Neurobiol; 2023 Aug; 60(8):4731-4737. PubMed ID: 37148523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female-specific effect of the BDNF gene on Alzheimer's disease.
    Li GD; Bi R; Zhang DF; Xu M; Luo R; Wang D; ; Fang Y; Li T; Zhang C; Yao YG
    Neurobiol Aging; 2017 May; 53():192.e11-192.e19. PubMed ID: 28202203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse.
    Alonso-Vanegas MA; Fawcett JP; Causing CG; Miller FD; Sadikot AF
    J Comp Neurol; 1999 Oct; 413(3):449-62. PubMed ID: 10502251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF genetic variations increase the risk of Alzheimer's disease-related depression.
    Borroni B; Grassi M; Archetti S; Costanzi C; Bianchi M; Caimi L; Caltagirone C; Di Luca M; Padovani A
    J Alzheimers Dis; 2009; 18(4):867-75. PubMed ID: 19661618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.